Facial Wasting Fillers: CMS Considers Question Of Coverage Qualification
This article was originally published in The Gray Sheet
Executive Summary
CMS says it is deciding whether reconstructive treatments for facial lipodystrophy syndrome, associated with human immunodeficiency virus medicines, can qualify for Medicare coverage under a statute that excludes cosmetic surgery from the federal program